SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-171467
Filing Date
2018-05-23
Accepted
2018-05-23 08:44:03
Documents
7
Period of Report
2018-05-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d587288d8k.htm 8-K 46054
2 EX-3.1 d587288dex31.htm EX-3.1 6341
3 EX-3.2 d587288dex32.htm EX-3.2 4838
4 EX-10.1 d587288dex101.htm EX-10.1 133234
5 EX-10.2 d587288dex102.htm EX-10.2 130925
6 EX-99.1 d587288dex991.htm EX-99.1 8588
7 GRAPHIC g587288g0522132713878.jpg GRAPHIC 3425
  Complete submission text file 0001193125-18-171467.txt   336508
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 18854133
SIC: 2835 In Vitro & In Vivo Diagnostic Substances